Lucet B - Search Results

1

Dynamic versus static compliance of the carotid artery in living Wistar-Kyoto rats.

Glaser E, Lacolley P, Boutouyrie P, Sacunha R, Lucet B, Safar ME, Laurent S. Glaser E, et al. Among authors: lucet b. J Vasc Res. 1995 Jul-Aug;32(4):254-65. doi: 10.1159/000159100. J Vasc Res. 1995. PMID: 7654882

2

Aortic distensibility and structural changes in sinoaortic-denervated rats.

Lacolley P, Bezie Y, Girerd X, Challande P, Benetos A, Boutouyrie P, Ghodsi N, Lucet B, Azoui R, Laurent S. Lacolley P, et al. Among authors: lucet b. Hypertension. 1995 Aug;26(2):337-40. doi: 10.1161/01.hyp.26.2.337. Hypertension. 1995. PMID: 7635544

3

Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats.

Lacolley P, Safar ME, Lucet B, Ledudal K, Labat C, Benetos A. Lacolley P, et al. Among authors: lucet b. J Am Coll Cardiol. 2001 Feb;37(2):662-7. doi: 10.1016/s0735-1097(00)01129-3. J Am Coll Cardiol. 2001. PMID: 11216994 Free article.

4

Central cardiovascular effects of dihydropyridines in spontaneously hypertensive rats.

Laurent S, Brisac AM, Champeroux P, Lacolley P, Huguet F, Legrand M, Lucet B, Tsoucaris D, Briand V, Schmitt H. Laurent S, et al. Among authors: lucet b. Fundam Clin Pharmacol. 1989;3 Suppl:47s-56s. doi: 10.1111/j.1472-8206.1989.tb00474.x. Fundam Clin Pharmacol. 1989. PMID: 2693290 Review.

5

Central and peripheral hypotensive effects of the optical isomers of nicardipine, a dihydropyridine calcium channel antagonist, in rats.

Brisac AM, Champéroux P, Lucet B, Laurent S, Schmitt H. Brisac AM, et al. Among authors: lucet b. Eur J Pharmacol. 1988 Jan 27;146(1):171-4. doi: 10.1016/0014-2999(88)90499-2. Eur J Pharmacol. 1988. PMID: 3350056

6

Central interactions between dihydropyridines and cholinergic systems in the control of blood pressure in rat.

Brisac AM, Huguet F, Champeroux P, Montastruc JL, Lucet B, Gerard P, Laurent S, Narcisse G, Schmitt H. Brisac AM, et al. Among authors: lucet b. Brain Res. 1987 Dec 1;435(1-2):160-6. doi: 10.1016/0006-8993(87)91597-6. Brain Res. 1987. PMID: 2448012

7

Effects of nicergoline on the cardiovascular system of dogs and rats.

Huchet AM, Mouillé P, Chelly J, Lucet B, Doursout MF, Lechat P, Schmitt H. Huchet AM, et al. Among authors: lucet b. J Cardiovasc Pharmacol. 1981 Jul-Aug;3(4):677-91. doi: 10.1097/00005344-198107000-00003. J Cardiovasc Pharmacol. 1981. PMID: 6167799

8

Pharmacological properties of AR-C239, 2-[2-[4(o-methoxyphenyl)-piperazine-1-Yl]-ethyl]4,4-dimethyl-1,3(2H-4H) isoquinolinedione, a new alpha-adrenoceptor blocking drug.

Mouillé P, Huchet AM, Chelly J, Lucet B, Doursout MF, Schmitt H. Mouillé P, et al. Among authors: lucet b. J Cardiovasc Pharmacol. 1980;2(2):175-91. doi: 10.1097/00005344-198003000-00009. J Cardiovasc Pharmacol. 1980. PMID: 6171685

9

Further investigations on the alpha 1-adrenoceptor blocking properties of AR-C 239 in rats.

Huchet AM, Andréjak M, Lucet B, Gautret B, Doursout MF, Ostermann G, Schmitt H. Huchet AM, et al. Among authors: lucet b. Clin Exp Pharmacol Physiol. 1985 Sep-Oct;12(5):505-13. doi: 10.1111/j.1440-1681.1985.tb00901.x. Clin Exp Pharmacol Physiol. 1985. PMID: 2867845

10

Interactions between clonidine and alpha-adrenoceptor blocking drugs on the tachycardic response to stimulation of the cardiac nerve in dogs.

Mouillé P, Huchet AM, Lucet B, Chelly J, Schmitt H. Mouillé P, et al. Among authors: lucet b. J Cardiovasc Pharmacol. 1979 Sep-Oct;1(5):515-28. doi: 10.1097/00005344-197909000-00004. J Cardiovasc Pharmacol. 1979. PMID: 94408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters